Mannatech Launches First Phase of Singapore Expansion

Mannatech, Incorporated (NASDAQ:MTEX), a leading developer and provider of dietary supplements and skin care solutions, announced today it has begun selling products in Singapore as of November 1.

With this opening, independent sales Associates are eligible for enrollment in Singapore. To commemorate the opening of the company’s 12^th international market, a flag raising ceremony will take place at Mannatech headquarters in Coppell, Texas, in early November.

Products immediately available in Singapore include the Mannatech Optimal Health System, which is comprised of Advanced Ambrotose® glyconutritional dietary supplement; Ambrotose AO® antioxidant supplement; PLUS™ herbal-amino acid supplement; and MannaMatrix® caplets — Mannatech’s proprietary plant and whole food-based multivitamin and mineral supplement, known as PhytoMatrix™ caplets in other markets. The MannaBears® supplement, designed specifically for children, is also available.

"The opening of Singapore is a great achievement for our company as we look toward continued international growth and success,” said Wayne Badovinus, president and CEO of Mannatech. "With our updated computer infrastructure, we are able to streamline international operations and simplify entry into new markets around the globe.”

Mannatech Singapore’s operations are currently being managed out of the company’s Australian office. Additionally, select materials are available for business-building activities and have been customized for the Singapore market, including:

• Join Us brochure
• Optimal Health brochure
• MannaBears® brochure
• Associate Policies and Procedures
• Compensation Plan
• Associate Application form
• Member Application form
• Pack/Product price list

A series of meetings will take place from Nov. 3-6 at The Grand Plaza Park Hotel, City Hall – 10 Coleman St., Singapore. These meetings will give Associates and other interested parties in the area a chance to meet one-on-one with the Mannatech corporate staff to learn about product training, business opportunities and tips and the company’s compensation plan.

About Mannatech

Mannatech, Incorporated is a global wellness solutions provider of innovative, high-quality, proprietary dietary supplements, skin care products and weight and fitness products sold through independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa and Singapore. For more information please visit www.mannatech.com or www.allaboutmannatech.com.

Please Note: This release contains "forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, including any litigation arising with respect to the previously disclosed "Wells Notices” received from the Securities and Exchange Commission, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.